STOCK TITAN

Femasys Inc. (FEMY) director awarded stock options for 880 shares at $3.67

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Femasys Inc. director Alistair Milnes received a new stock option award. On 2026-06-24, he was granted options to acquire 880 shares of Femasys common stock at an exercise price of $3.67 per share, expiring on 2036-06-24. The underlying shares vest one year from the grant date, assuming continued service, and this grant brings his directly held stock options from this award to 880 options.

Positive

  • None.

Negative

  • None.
Insider Milnes Alistair
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F1 880 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 880 shares (Direct)
Footnotes (1)
  1. F1. The shares underlying the stock option vest one year from the date of grant, assuming continued service.
Options Granted 880 shares Stock option grant to director Alistair Milnes on 2026-06-24
Exercise Price $3.67 per share Conversion or exercise price of the stock option award
Expiration Date 2036-06-24 Expiration of the reported stock option grant
Underlying Shares 880 shares Common stock underlying the stock option (right to buy)
Post-transaction Options 880 options Total options from this award held after the grant
Stock Option (Right to Buy) financial
"The security is described as a Stock Option (Right to Buy)."
exercise price financial
"The conversion or exercise price is $3.6700 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"The shares underlying the stock option vest one year from the date of grant."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
underlying security financial
"The underlying security title is listed as Common Stock."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did FEMY director Alistair Milnes report in this Form 4?

Alistair Milnes reported a grant of stock options for 880 shares of Femasys Inc. common stock, received on 2026-06-24, with an exercise price of $3.67 per share and expiration on 2036-06-24.

What is the exercise price of the new FEMY stock options?

The new options reported by Alistair Milnes have an exercise price of $3.67 per share. This is the price at which he may buy Femasys common stock upon exercise of the 880 underlying shares.

When do Alistair Milnes’s FEMY options vest and expire?

The options vest one year from the 2026-06-24 grant date, assuming continued service. They have an expiration date of 2036-06-24, after which any unexercised portion of the 880-share grant will lapse.

How many FEMY option shares does Alistair Milnes hold after this grant?

Following this reported transaction, Alistair Milnes holds 880 stock options from this award. Each option relates to one share of Femasys common stock at an exercise price of $3.67 per share.

Was the FEMY Form 4 transaction a purchase or a grant?

The Form 4 reports a grant/award acquisition of stock options, coded as transaction type “A”. It is not an open-market share purchase or sale but a compensation-related option award for 880 shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Milnes Alistair

(Last)(First)(Middle)
C/O FEMASYS INC.
3950 JOHNS CREEK COURT, SUITE 100

(Street)
SUWANEE GEORGIA 30024

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
FEMASYS INC [ FEMY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$3.6706/24/2026A880 (1)06/24/2036Common Stock880$0880D
Explanation of Responses:
1. The shares underlying the stock option vest one year from the date of grant, assuming continued service.
/s/ Kathy Lee-Sepsick, Attorney-in-fact08/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)